Moreover, it has been demonstrated that targeting the conserved cysteine (C274) residue of NR0B1 disrupts NR0B1 protein complexes, altering the transcriptional output and growth of NRF2-activated cancer cells [7]. The gene discussed is NR0B1; the disease is cancer.